Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV
Learn more about:
Related Clinical Trial
A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection
Disease Loads and Status of Treatment
Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection
Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV
Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus
Epidemiology of Hepatitis B, C and Delta in Reunion Island
Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
A Long Term Follow-up Study of Patients From the REP 301 Protocol
Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta
Phase 2b Study of Bulevirtide (With Peginterferon Alfa-2a) in Patients With CHD
A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)
Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D
A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.
Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
HIDIT II – PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis
Ezetimibe for Patients With Chronic Hepatitis D
Lonafarnib for Chronic Hepatitis D
Phase 3 Study of Bulevirtide in Patients With CHD
Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon
An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)
Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Pegylated Interferon to Treat Chronic Hepatitis D
The Hepatitis Delta International Network